Based on their previous work, they identified that the PI3K/Akt/mechanistic target of rapamycin (mTOR) signaling was implicated in myofibroblast differentiation in SSc patients and Akt is also implicated in BLT1 signaling. Here, MTOR is linked to systemic sclerosis.